BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11876000)

  • 1. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
    Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
    Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
    Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
    Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
    Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
    Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
    Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
    Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.
    Whitney MA; Saito H; Jakobs PM; Gibson RA; Moses RE; Grompe M
    Nat Genet; 1993 Jun; 4(2):202-5. PubMed ID: 8348157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
    Li L; Eng C; Desnick RJ; German J; Ellis NA
    Mol Genet Metab; 1998 Aug; 64(4):286-90. PubMed ID: 9758720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid method for detecting the predominant Ashkenazi Jewish mutation in the Bloom's syndrome gene.
    Straughen JE; Johnson J; McLaren D; Proytcheva M; Ellis N; German J; Groden J
    Hum Mutat; 1998; 11(2):175-8. PubMed ID: 9482582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for the BLM(Ash) mutation and cancer risk.
    Cleary SP; Zhang W; Di Nicola N; Aronson M; Aube J; Steinman A; Haddad R; Redston M; Gallinger S; Narod SA; Gryfe R
    Cancer Res; 2003 Apr; 63(8):1769-71. PubMed ID: 12702560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.
    Bronstein S; Karpati M; Peleg L
    Isr Med Assoc J; 2014 Nov; 16(11):683-5. PubMed ID: 25558695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
    Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
    Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
    Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
    J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage disequilibrium between the FES, D15S127, and BLM loci in Ashkenazi Jews with Bloom syndrome.
    Ellis NA; Roe AM; Kozloski J; Proytcheva M; Falk C; German J
    Am J Hum Genet; 1994 Sep; 55(3):453-60. PubMed ID: 8079989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews.
    Oddoux C; Clayton CM; Nelson HR; Ostrer H
    Am J Hum Genet; 1999 Apr; 64(4):1241-3. PubMed ID: 10090915
    [No Abstract]   [Full Text] [Related]  

  • 19. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI deficiency in Ashkenazi Jews in Israel.
    Asakai R; Chung DW; Davie EW; Seligsohn U
    N Engl J Med; 1991 Jul; 325(3):153-8. PubMed ID: 2052060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.